Karyopharm Therapeutics Inc. — Form D

Karyopharm Therapeutics Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-08. The offering totals $165.0M, of which $165.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Garen G BohlinDirectorNewton, MA
Barry E GreeneDirectorNewton, MA
Peter G HonigDirectorNewton, MA
Mansoor Raza MirzaDirectorNewton, MA
Christy J OligerDirectorNewton, MA
Deepika R PakianathanDirectorMountain View, CA
Richard PaulsonDirectorNewton, MA
Chen R SchorDirectorNewton, MA
Sohanya ChengExecutive OfficerNewton, MA
Michael ManoExecutive OfficerNewton, MA
Michael MasonExecutive OfficerNewton, MA
Stephen MitchenerExecutive OfficerNewton, MA
Richard PaulsonExecutive OfficerNewton, MA
Stuart PoultonExecutive OfficerNewton, MA
Reshma RangwalaExecutive OfficerNewton, MA
Sharon ShachamExecutive OfficerTEL AVIV, L3
Paul BrannellyExecutive OfficerCambridge, MA
MICHAEL KAUFFMANDirectorNEEDHAM, MA
MICHAEL KAUFFMANExecutive OfficerNEEDHAM, MA
Alan BarberExecutive OfficerWellesley, MA
Barry Raza GreeneDirectorNatick, MA
Deepika E PakianathanDirectorNatick, MA
Sharon E ShachamExecutive OfficerNatick, MA
Kenneth E WegDirectorNatick, MA
Ronald DePinhoDirectorCambridge, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2013-08-01D$19.0M$19.0M
2013-05-01D$60.0M$20.5M
2010-11-05D$20.8M$700K

More